CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
Intravenous ganciclovir and, increasingly, oral valganciclovir are now considered the mainstay of treatment for cytomegalovirus (CMV) infection or CMV disease. Under certain circumstances, CMV immunoglobulin (CMVIG) may be an appropriate addition or, indeed, alternative. Data on monotherapy with CMV...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Lippincott Williams & Wilkins
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764017/ |